[go: up one dir, main page]

HK1108168A1 - Vaccine for prevention and treatment of hiv-infection - Google Patents

Vaccine for prevention and treatment of hiv-infection Download PDF

Info

Publication number
HK1108168A1
HK1108168A1 HK07111226.6A HK07111226A HK1108168A1 HK 1108168 A1 HK1108168 A1 HK 1108168A1 HK 07111226 A HK07111226 A HK 07111226A HK 1108168 A1 HK1108168 A1 HK 1108168A1
Authority
HK
Hong Kong
Prior art keywords
nef
gag
polypeptide
composition
protein
Prior art date
Application number
HK07111226.6A
Other languages
German (de)
English (en)
French (fr)
Chinese (zh)
Other versions
HK1108168B (en
Inventor
Helge Abrecht
Martine Delchambre
Martine Marchand
Nathalie Louise Mathy
Philippe Jean Gervais Ghislain Permanne
Gerald Hermann Voss
Original Assignee
Glaxosmithkline Biologicals S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxosmithkline Biologicals S.A. filed Critical Glaxosmithkline Biologicals S.A.
Publication of HK1108168A1 publication Critical patent/HK1108168A1/en
Publication of HK1108168B publication Critical patent/HK1108168B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/64—Medicinal preparations containing antigens or antibodies characterised by the architecture of the carrier-antigen complex, e.g. repetition of carrier-antigen units
    • A61K2039/645—Dendrimers; Multiple antigen peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
    • C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16311—Human Immunodeficiency Virus, HIV concerning HIV regulatory proteins
    • C12N2740/16322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • AIDS & HIV (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
HK07111226.6A 2004-08-05 2005-08-03 Vaccine for prevention and treatment of hiv-infection HK1108168B (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0417494.2 2004-08-05
GBGB0417494.2A GB0417494D0 (en) 2004-08-05 2004-08-05 Vaccine
PCT/EP2005/008434 WO2006013106A2 (en) 2004-08-05 2005-08-03 Vaccine for prevention and treatment of hiv-infection

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
HK10102984.2A Division HK1135139A (en) 2004-08-05 2007-10-17 Vaccine for prevention and treatment of hiv-infection

Related Child Applications (1)

Application Number Title Priority Date Filing Date
HK10102984.2A Addition HK1135139A (en) 2004-08-05 2007-10-17 Vaccine for prevention and treatment of hiv-infection

Publications (2)

Publication Number Publication Date
HK1108168A1 true HK1108168A1 (en) 2008-05-02
HK1108168B HK1108168B (en) 2010-06-04

Family

ID=

Also Published As

Publication number Publication date
ZA200700771B (en) 2009-04-29
WO2006013106A2 (en) 2006-02-09
MY145614A (en) 2012-03-15
CN101035897B (zh) 2012-02-01
MA28983B1 (fr) 2007-11-01
PL1773999T3 (pl) 2010-02-26
CA2575898C (en) 2015-09-29
EP2280073B1 (en) 2014-06-11
JP5629647B2 (ja) 2014-11-26
BRPI0514108A (pt) 2008-05-27
NZ552976A (en) 2010-01-29
EP2130921A3 (en) 2010-03-03
CN101035897A (zh) 2007-09-12
CA2575898A1 (en) 2006-02-09
TW200621806A (en) 2006-07-01
KR101501495B1 (ko) 2015-03-11
DE602005016810D1 (de) 2009-11-05
PE20060577A1 (es) 2006-08-07
AR080216A2 (es) 2012-03-21
US7612173B2 (en) 2009-11-03
HRP20090678T1 (hr) 2010-01-31
RU2441878C2 (ru) 2012-02-10
SG155206A1 (en) 2009-09-30
AU2005268856B2 (en) 2012-05-24
KR20070041765A (ko) 2007-04-19
ES2445453T3 (es) 2014-03-03
SI1773999T1 (sl) 2010-01-29
RU2007104088A (ru) 2008-09-10
ATE443769T1 (de) 2009-10-15
IL180947A0 (en) 2007-07-04
IL207575A0 (en) 2011-07-31
CY1109667T1 (el) 2014-08-13
CN102633866A (zh) 2012-08-15
EP2130921A2 (en) 2009-12-09
US20070243203A1 (en) 2007-10-18
AR050102A1 (es) 2006-09-27
GB0417494D0 (en) 2004-09-08
ES2486669T3 (es) 2014-08-19
CN102633866B (zh) 2015-04-15
TWI365191B (en) 2012-06-01
NO20070988L (no) 2007-05-04
US20100184836A1 (en) 2010-07-22
WO2006013106A3 (en) 2006-08-17
EP1773999B1 (en) 2009-09-23
EP2130921B1 (en) 2013-11-20
PT1773999E (pt) 2009-12-16
JP2008507987A (ja) 2008-03-21
JP6007212B2 (ja) 2016-10-12
AU2005268856A1 (en) 2006-02-09
DK1773999T3 (da) 2010-01-18
MX2007001515A (es) 2007-09-07
ES2334044T3 (es) 2010-03-04
EP2280073A2 (en) 2011-02-02
EP1773999A2 (en) 2007-04-18
EP2280073A3 (en) 2011-06-29
JP2014239687A (ja) 2014-12-25
JP2011234722A (ja) 2011-11-24

Similar Documents

Publication Publication Date Title
EP1773999B1 (en) Vaccine for prevention and treatment of hiv-infection
US20100285051A1 (en) Vaccine
US20090104229A1 (en) Novel use
HK1108168B (en) Vaccine for prevention and treatment of hiv-infection
HK1135139A (en) Vaccine for prevention and treatment of hiv-infection
HK1147282A (en) Vaccine for prevention and treatment of hiv-infection
TW200940094A (en) Vaccine

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20140803